References
- RascalouGPontierDMenuFGourbiereSEmergence and prevalence of human vector-borne diseases in sink vector populationsPloS One20127e3685822629337
- HotezPJMolyneuxDHFenwickAControl of neglected tropical diseasesN Engl J Med20073571018102717804846
- GoyaGFFernandez-PachecoRArrueboMCassinelliNIbarraMRBrownian rotational relaxation and power absorption in magnetite nanoparticlesJ Magn Magn Mater2007316132135
- LacroixLMMalakiRBCarreyJMagnetic hyperthermia in single-domain monodisperse FeCo nanoparticles: evidences for Stoner- Wohlfarth behavior and large lossesJ Appl Phys20091052
- SantosDMCarneiroMWde MouraTRTowards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11Int J Nanomedicine201272115212722619548
- Danesh-BahreiniMAShokriJSamieiAKamali-SarvestaniEBarzegar-JalaliMMohammadi-SamaniSNanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c miceInt J Nanomedicine2011683584221589651
- VyasSPGuptaSOptimizing efficacy of amphotericin B through nanomodificationInt J Nanomedicine2006141743217722276
- BoscardinSBTorrecilhasACManarinRChagas’ disease: an update on immune mechanisms and therapeutic strategiesJ Cell Mol Med2010141373138420070438
- Pinto DiasJCThe treatment of Chagas disease (South American trypanosomiasis)Ann Intern Med200614477277416702594
- FilardiLSBrenerZSusceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas diseaseTrans R Soc Trop Med Hyg1987817557593130683
- WilkinsonSRKellyJMTrypanocidal drugs: mechanisms, resistance and new targetsExpert Rev Mol Med200911e3119863838
- PepinJMilordFKhondeANiyonsengaTLokoLMpiaBGambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapyTrans R Soc Trop Med Hyg1994884474527570842
- GotoHLindosoJACurrent diagnosis and treatment of cutaneous and mucocutaneous leishmaniasisExpert Rev Anti Infect Ther2010841943320377337
- BermanJDHuman leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 yearsClin Infect Dis1997246847039145744
- BermanJDUS Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasisClin Infect Dis199928495110391695
- JordanAWustPFahlingHJohnWHinzAFelixRInductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermiaInt J Hyperthermia20092549951119848612
- GoyaGFGrazuVIbarraMRMagnetic nanoparticles for cancer therapyCurr Nanosci008;4116
- LeeJ-HJangJ-TChoiJ-SExchange-coupled magnetic nanoparticles for efficient heat inductionNat Nanotechnol2011641842221706024
- LevyMWilhelmCSiaugueJMHornerOBacriJCGazeauFMagnetically induced hyperthermia: size-dependent heating power of gamma-Fe(2)O(3) nanoparticlesJ Phys Condens Matter20082020413321694262
- CominiMMengeUWissingJFloheLTrypanothione synthesis in Crithidia revisitedJ Biol Chem20052806850686015537651
- VergesMACostoRRocaAGUniform and water stable magnetite nanoparticles with diameters around the monodomain-multidomain limitJ Phys D Appl Phys20084113
- Gonzalez-FernandezMATorresTEAndres-VergesMMagnetic nanoparticles for power absorption: optimizing size, shape and magnetic propertiesJ Solid State Chem200918227792784
- GoyaGFHandling the particle size and distribution of Fe3O4 nanoparticles through ball millingSolid State Commun2004130783787
- HergtRDutzSRoderMEffects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermiaJ Phys Condens Matter20082038521421693832
- HilgerIFruhaufKAndraWHiergeistRHergtRKaiserWAHeating potential of iron oxides for therapeutic purposes in interventional radiologyAcad Radiol2002919820211918373
- Pineiro-RedondoYBanobre-LopezMPardinas-BlancoIGoyaGLopez-QuintelaMARivasJThe influence of colloidal parameters on the specific power absorption of PAA-coated magnetite nanoparticlesNanoscale Res Lett2011638321711915
- GoyaGFMarcos-CamposIFernandez-PachecoRDendritic cell uptake of iron-based magnetic nanoparticlesCell Biol Int2008321001100518534870
- Marcos-CamposIAsinLTorresTECell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cellsNanotechnology20112220510121444956
- VillanuevaAde la PresaPAlonsoJMHyperthermia HeLa cell treatment with silica-coated manganese oxide nanoparticlesJ Phys Chem C201011419761981
- RichardsonHHCarlsonMTTandlerPJHernandezPGovorovAOExperimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutionsNano Lett200991139114619193041
- SchildkopfPFreyBMantelFApplication of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cellsBiochem Biophys Res Commun20103911014102019968962
- PeterMEProgrammed cell death: apoptosis meets necrosisNature201147131031221412328
- CreixellMBohorquezACTorres-LugoMRinaldiCEGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature riseACS Nano201157124712921838221
- AsínLIbarraMTresAGoyaGFControlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentrationPharm Res20122951319132722362408
- LunovOZablotskiiVPastorJMThermal destruction on the nanoscale: cell membrane hyperthermia with functionalized magnetic nanoparticlesHafeliUSchuttWZborowskiM8th International Conference on the Scientific and Clinical Applications of Magnetic Carriers1311Melville, NYAmer Inst Physics2010